A Patient-Centric Hemostatic Strategy
When planning surgery, patient factors including coagulation status and bleeding severity should be at the core of your hemostatic strategy.
Patient profiles are changing; increasing the risk of bleeding complications.1
15%
of US adults have chronic kidney disease.2
30%
of the US population use low-dose aspirin for cardiovascular disease prevention.3
~2/3
of surgical patients are treated with anticoagulants and/or antiplatelets.*4
*Based on Premier Database data
~1 in 50
adults have liver disease.5
~2 in 5
adults will be diagnosed with cancer in their lifetime.6
Patients at the core.
Each patient is unique, with their own set of factors that impact their risk of bleeding related complications.
Some patients have an intact coagulation and relatively good health while others have compromised coagulation and existing comorbidities.
These factors can all influence the risk of bleeding7 and the performance of adjunctive hemostats agents and sealants.1
Choosing the right hemostatic product for your patient could lead to improved surgical outcomes and lower hospital costs.1
Passive hemostatic agents are effective in patients with intact coagulation.1
Active hemostatic agents are effective in patients with compromised and intact coagulation.1
The United States Food and Drug Administration (FDA) now requires the use of a validated bleeding severity scale in clinical studies investigating hemostatic agents.9
The use of a validated bleeding scale could ultimately improve surgical efficiency by selecting the right adjunctive hemostatic agent for the right bleed. Choosing the appropriate adjunctive hemostatic agent may lead to:
Improved patient outcomes1,10
Fewer blood transfusions1,10
Reduced hospital costs1,10
Reduced length of hospital stay1,10
The VIBe SCALE tool is the first surgeon-validated FDA accepted scale designed for consistent and reliable assessment of intraoperative bleeding severity.9
Grade 0: No Bleeding
- Kidney Abrasion. Grade 0 reflects clinically insignificant and unremarkable bleeds.
Grade 1: Mild
- Capsular Liver Abrasion. Grade 1 bleeds represent a general ooze, which well up over 1-2 minutes after blotting with gauze.
Grade 2: Moderate
- Grade 2 bleeds visibly well up after blotting, and are usually considered distracting to the surgical procedure.
Grade 3: Severe
- Rupture of venous plexus during posterior lumbar laminectomy. Grade 3 bleeds well up immediately after blotting, and require treatment to continue with the surgery.
Grade 4: Life Threatening
- Abdominal Aortic Tear. Grade 4 bleeds are life-threatening and require immediate surgical treatment.
Considering your patients profile, while critical, is only part of an effective hemostasis strategy.
Proactive decision-making around patient blood management with patients at the core.
"As with all novel developments in medicine, adoption of new processes take time to become mainstream. Just as patient blood management has taken years to be accepted and is now the standard of care, so will the VIBe SCALE Tool follow as a way to characterize surgical bleeding."
Dr. Pierre Tibi, MD, FACS
